Files
janssen/Medidata/downloads/2026-05-20_15-21_EDC_MDD3003_QueryDetails.csv
T

4.0 KiB

1Country/RegionSite NumberSitesSubjectsSubject StatusVisitsPagesQueries (Op/Ans/SDV)RecordPositionFieldQuery GroupQueryID(ReQry)QueryStatusOpened ByOpened DateAnswered ByAnswered DateClosed ByClosed DateDaysNotYetClosedDays to AnswerDays to CloseQueryTextAnswer Text (if any)StudyParameterSiteGroupParameterSiteNumberParameterSiteParameterSubjectParameterSubjectStatusParameterFolderParameterFormParameterFieldParameterMarkingGroupParameterQueryStatusParameterIncludeInactivePagesParameterPageSDVParameterPageFrozenParameterPageLockedParameterStartDateParameterEndDateParameterMilestoneParameterReportTypeParameterVersionNumberPrintDateTimeTimeZoneRunUserErrorStringOpenedDateSrtbleAnsweredDateSrtbleClosedDateSrtbleVisitSiteLevelVisitCountryLevelVisitStudyLevelPageSubjectLevelPageSiteLevelPageCountryLevelPageStudyLevel
2CZES10-CZ10004Medical Services Prague s.r.o.CZ100040006EnrolledVisit 8 Part 1 (1)Date of Visit0/1/NDid this visit occur?DM20915933Answeredshyamaprasad97219 May 2026 12:47:10:123EHerman220 May 2026 12:02:23:56711Medical Review I-12758914: Kindly provide the clinical significance of high triglyceride as there is reported hypercholesterolemia in MH page. Kindly clarify if there is any worsening of existing MH.not clinically significant42847922MDD3003 [Prod]CZEAllAllAllNoneAllAllAllAllOpen,AnsweredNoNoneNoneNoneNoneNoneFinalWith Text5.6 - 1.05/20/2026 1:21:29 PMGMTVladimir Buzalka [Site Manager]20260519 12:47:10.12320260520 12:02:23.5671441144
3CZES10-CZ10011MEDIPA s r oCZ100110008EnrolledVisit 1.7 Induction (1)Date of Visit1/0/NSubject's StatusDM20911926Open(R)shyamaprasad97219 May 2026 11:26:37:2171Medical Review I-12758916: Please comment on the clinical significance of higher-than-normal levels of GGT.42847922MDD3003 [Prod]CZEAllAllAllNoneAllAllAllAllOpen,AnsweredNoNoneNoneNoneNoneNoneFinalWith Text5.6 - 1.05/20/2026 1:21:29 PMGMTVladimir Buzalka [Site Manager]20260519 11:26:37.2172441244
4CZES10-CZ10011MEDIPA s r oCZ100110010EnrolledStudy Drug Administration (1)Study Drug Administration Open Label Part 2 - Stabilization1/0/R1Start DateAuto20908883Open(R)systemuser19 May 2026 09:28:33:8101Please enter study drug administration start date as soon as it's available42847922MDD3003 [Prod]CZEAllAllAllNoneAllAllAllAllOpen,AnsweredNoNoneNoneNoneNoneNoneFinalWith Text5.6 - 1.05/20/2026 1:21:29 PMGMTVladimir Buzalka [Site Manager]20260519 09:28:33.8102441244
5CZES10-CZ10012Neuropsychiatrie Petrska sroCZ100120005Early TerminatedInvestigator Periodic Review Acknowledgments/ Interim Signatures Periodic Investigator's EDC Review Acknowledgement1/0/NAs the investigator, I have ensured the accuracy, completeness, and timeliness of the data reported to the sponsor in the CRFs.Auto20876096Opensystemuser17 May 2026 08:22:12:2873NOTIFICATION: Date of discontinuation/completion has been completed for the subject. To ensure compliance with regulatory requirements for data oversight, please mark the tick box after you have reviewed the subject’s data in EDC.42847922MDD3003 [Prod]CZEAllAllAllNoneAllAllAllAllOpen,AnsweredNoNoneNoneNoneNoneNoneFinalWith Text5.6 - 1.05/20/2026 1:21:29 PMGMTVladimir Buzalka [Site Manager]20260517 08:22:12.2871441144